Stephen R. Allen

This profile gathers the share dealings of Stephen R. Allen in Niagen Bioscience, Inc. Between 20 March 2017 and 25 August 2017, the trades on record add up to 3 filings.

Every open-market trade on record is a purchase: 3 purchases worth €19k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €5,609 and half below. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +40.2%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 28 August 2017: an open-market purchase of €5,609, in Niagen Bioscience, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.